Novo Nordisk A/S ADR sell Morgan Stanley
Start price
29.09.25
/
50%
€45.95
Target price
29.09.26
€40.10
Performance (%)
-10.99%
Price
11:56
€40.90
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR shows a convincing performance of -10.99%. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -2.249% | -2.249% |
| iShares Core DAX® | -4.597% | -5.624% |
| iShares Nasdaq 100 | -2.857% | -3.328% |
| iShares Nikkei 225® | -4.211% | -5.242% |
| iShares S&P 500 | -2.037% | -1.850% |
Comments by Morgan_Stanley for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating. They now have a $47.00 price target on the stock, down previously from $59.00.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€95.40
23.01.24
23.01.24
€110.32
23.01.25
23.01.25
-18.03%
24.01.25
24.01.25
